Zhongze Therapeutics

company

About

Clinical-stage Biotech

Details

Last Funding Type
Seed
Industries
Biotechnology
Founded date
Jul 23, 2021
Operating Status
Active

ZHONGZE Therapeutics is a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological disorders.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Zhongze Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 21, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2022 Seed 1 CQY Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Zhongze Therapeutics is funded by 1 investors. CQY Capital are the most recent investors.
Investor Name Lead Investor Funding Round
CQY Capital Yes Seed